We are live on
!
Find out more
FIA
FNY Investment Advisers Portfolio holdings
AUM
$278M
1-Year Est. Return
98.99%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$78.9M
AUM Growth
-$8.45M
(-9.7%)
Cap. Flow
-$8.23M
Cap. Flow
% of AUM
-10.43%
Top 10 Holdings %
Top 10 Hldgs %
39.35%
Holding
803
New
189
Increased
92
Reduced
66
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$6.36M |
| 2 |
Labcorp
LH
|
+$2.9M |
| 3 |
BorgWarner
BWA
|
+$2.42M |
| 4 |
FRG
Franchise Group, Inc.
FRG
|
+$2.15M |
| 5 |
UNVR
Univar Solutions Inc.
UNVR
|
+$1.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
+$8.19M |
| 2 |
Vodafone
VOD
|
+$3.69M |
| 3 |
MGI
MoneyGram International, Inc. New
MGI
|
+$2.78M |
| 4 |
Intel
INTC
|
+$2.42M |
| 5 |
ASML
ASML
|
+$2.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.37% |
| 2 | Technology | 14.3% |
| 3 | Industrials | 13.87% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Materials | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCVI
126
DELISTED
Churchill Capital Corp VI
CCVI
| $77K | 0.1% |
7,560
-15,000
| -66% | -$153K |
|
127
General Mills
GIS
$20.2B
| $76K | 0.1% |
+1,000
| New | +$85.5K |
|
128
Tronox
TROX
$1.02B
| $76K | 0.1% |
+6,000
| New | +$75.4K |
|
129
Strategy Inc
MSTR
$37.8B
| $75K | 0.1% |
2,200
+1,200
| +120% | +$36.4K |
|
|
SWN
130
DELISTED
Southwestern Energy Company
SWN
| $75K | 0.1% |
12,500
+2,500
| +25% | +$12.9K |
|
|
SPLK
131
DELISTED
Splunk Inc
SPLK
| $75K | 0.1% |
715
-410
| -36% | -$39K |
|
132
Hershey
HSY
$36.6B
| $74K | 0.09% |
+300
| New | +$78.7K |
|
133
V2X
VVX
$2.52B
| $74K | 0.09% |
1,500
| – | – |
|
|
AIO
134
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$906M
| $73K | 0.09% |
4,000
-1,000
| -20% | -$17.1K |
|
135
InMode
INMD
$870M
| $73K | 0.09% |
1,966
| – | – |
|
136
Neuronetics
STIM
$222M
| $71K | 0.09% |
+33,389
| New | +$81K |
|
137
Antero Resources
AR
$11.6B
| $69K | 0.09% |
3,000
+1,000
| +50% | +$22.2K |
|
|
CDMO
138
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $69K | 0.09% |
+5,000
| New | +$85.2K |
|
139
Pinterest
PINS
$13.4B
| $68K | 0.09% |
2,500
+1,484
| +146% | +$37K |
|
|
BXMX
140
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $66K | 0.08% |
5,000
| – | – |
|
141
Equity Residential
EQR
$24.4B
| $64K | 0.08% |
980
-3,700
| -79% | -$231K |
|
|
DO
142
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $62K | 0.08% |
+4,400
| New | +$52.1K |
|
143
CAVA Group
CAVA
$7.08B
| $61K | 0.08% |
+1,504
| New | +$61.9K |
|
144
Lennar Class A
LEN
$21.1B
| $61K | 0.08% |
+506
| New | +$55.2K |
|
145
McCormick & Company Non-Voting
MKC
$14.2B
| $61K | 0.08% |
+700
| New | +$61.9K |
|
146
Evolv Technologies
EVLV
$1.08B
| $60K | 0.08% |
+10,000
| New | +$47.3K |
|
147
Expedia Group
EXPE
$38.5B
| $60K | 0.08% |
+550
| New | +$53.9K |
|
148
Moderna
MRNA
$24.2B
| $60K | 0.08% |
497
-11
| -2% | -$1.47K |
|
149
Rivian
RIVN
$23.7B
| $59K | 0.07% |
3,550
+3,500
| +7,000% | +$48.9K |
|
|
CFLT
150
DELISTED
Confluent
CFLT
| $58K | 0.07% |
+1,650
| New | +$46.2K |
|
Similar funds
ACP
KWM
CC
SL
BCH
CCC
NCM
RFA
FNY Investment Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, FNY Investment Advisers held 803 positions worth $78.9M, down 9.7% from $87.4M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
FNY Investment Advisers withdrew a net $8.23M in Q2 2023, closing 232 positions and reducing 66 holdings. Its most notable exit was Oak Street Health, Inc., an estimated $8.19M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
Against the trend, FNY Investment Advisers opened a new position in IVERIC bio, Inc. Common Stock worth $7.08M.
- FNY Investment Advisers's largest Q2 2023 buy was IVERIC bio, Inc. Common Stock: 180,106 shares worth $7.08M.
- FNY Investment Advisers added most to Univar Solutions Inc. in Q2 2023, an estimated $1.85M increase.
- FNY Investment Advisers's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $1.53M.
- FNY Investment Advisers fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $8.19M.
- FNY Investment Advisers's ten largest holdings make up 39% of its $78.9M portfolio in Q2 2023.
- FNY Investment Advisers opened 189 new positions and closed 232 in Q2 2023.
- FNY Investment Advisers's portfolio value fell 9.7% quarter-over-quarter to $78.9M.
Based on FNY Investment Advisers's 13F filing for Q2 2023, filed 11 Jul 2023.